Correlation Between Milestone Pharmaceuticals and VTv Therapeutics

Can any of the company-specific risk be diversified away by investing in both Milestone Pharmaceuticals and VTv Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Milestone Pharmaceuticals and VTv Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Milestone Pharmaceuticals and vTv Therapeutics, you can compare the effects of market volatilities on Milestone Pharmaceuticals and VTv Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Milestone Pharmaceuticals with a short position of VTv Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Milestone Pharmaceuticals and VTv Therapeutics.

Diversification Opportunities for Milestone Pharmaceuticals and VTv Therapeutics

0.15

Correlation Coefficient

Milestone Pharmaceuticals  VTv Therapeutics

Average diversification

The 3 months correlation between Milestone and VTv is 0.15. Overlapping area represents the amount of risk that can be diversified away by holding Milestone Pharmaceuticals and vTv Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on vTv Therapeutics and Milestone Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Milestone Pharmaceuticals are associated (or correlated) with VTv Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of vTv Therapeutics has no effect on the direction of Milestone Pharmaceuticals i.e., Milestone Pharmaceuticals and VTv Therapeutics go up and down completely randomly.

Pair Corralation between Milestone Pharmaceuticals and VTv Therapeutics

Given the investment horizon of 90 days Milestone Pharmaceuticals is expected to under-perform the VTv Therapeutics. In addition to that, Milestone Pharmaceuticals is 1.13 times more volatile than vTv Therapeutics. It trades about -0.09 of its total potential returns per unit of risk. vTv Therapeutics is currently generating about 0.08 per unit of volatility. If you would invest  1,397  in vTv Therapeutics on December 28, 2024 and sell it today you would earn a total of  338.00  from holding vTv Therapeutics or generate 24.19% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

Milestone Pharmaceuticals  vs.  vTv Therapeutics

Milestone Pharmaceuticals

Risk-Adjusted Performance

Weak

Over the last 90 days Milestone Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unsteady performance in the last few months, the Stock's basic indicators remain comparatively stable which may send shares a bit higher in April 2025. The newest uproar may also be a sign of mid-term up-swing for the firm private investors.

vTv Therapeutics

Risk-Adjusted Performance

Modest

Compared to the overall equity markets, risk-adjusted returns on investments in vTv Therapeutics are ranked lower than 6 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively weak basic indicators, VTv Therapeutics unveiled solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Milestone Pharmaceuticals and VTv Therapeutics

The main advantage of trading using opposite Milestone Pharmaceuticals and VTv Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Milestone Pharmaceuticals position performs unexpectedly, VTv Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in VTv Therapeutics will offset losses from the drop in VTv Therapeutics' long position.

The idea behind Milestone Pharmaceuticals and vTv Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Share Portfolio module to track or share privately all of your investments from the convenience of any device.